Cytovance recently appeared on the Outsourced Pharma Large Molecule Capabilities Update to share how our available capacity, experince in microbial and mammalian expression systems, US-based manufacturing facilities, and high scale-up success rate are helping industry customers meet product milestones. View the video below to hear from Rose Rhomberg, our Senior Director of Business Development, on […]
Outsourced Pharma Capabilities Update – March 2026 Read More »
